Blog

Monthly Market Update - January 2025

Market Data – January 2025

Market Returns - 1 Month to 31 January 2025 (in AUD)

Market Commentary 

January 2025 was marked by significant market volatility driven by the U.S presidential transition, AI disruption, and escalating trade tensions. Markets initially demonstrated resilience with major indices posting gains early in the month, but sentiment shifted following President Trump's inauguration and subsequent policy announcements.

The month concluded on a turbulent note as the U.S. administration imposed import tariffs - 25% on Canada and Mexico and 10% on China - later postponing those on Canada and Mexico following negotiations. This overshadowed an otherwise strong earnings season, with tech, healthcare, and industrial companies in the S&P 500 reporting double-digit year-over-year growth, exceeding analyst expectations. The surprise emergence of China's DeepSeek AI model disrupted U.S. tech dominance, triggering volatility in semiconductor and big tech stocks, notably NVIDIA, which suffered a historic $US600 billion single-day market value loss. Markets largely stabilised towards month-end as investors reassessed competitive dynamics.

Global central banks showed diverging policies, with the Bank of Japan unexpectedly hiking rates 25bps to 0.5% while other central banks, including Canda and Sweden maintained their steady stance. U.S. inflation data provided some relief, with core figures coming in softer than expected, although still running above Central bank targets.

In Australia, the Q4 CPI report revealed further moderation in trimmed mean inflation to 3.2% year-on-year from the prior 3.5%, with core inflation easing on lower housing and energy costs, potentially giving the RBA room to cut rates.

Looking ahead, markets face uncertainty from US trade policy implementations, tech sector disruption, and diverging global growth trajectories. While January concluded with generally positive returns - European markets up 8% in AUD terms and broader markets gaining 2-4%, alongside rising gold prices and falling bond yields. Despite a strong start to the year, the rapidly evolving landscape suggests continued volatility ahead

Australian Equities

The Prime Australian Equities Portfolio returned 3.1% in January 2025, in a month where domestic markets navigated both local economic developments and global uncertainties.

The Financial sector emerged as the portfolio's strongest contributor, returning 8.2%. Australian banks showed particular resilience despite concerns about mortgage stress, benefiting from the RBA's signals of potential rate cuts following Q4 CPI data showing core inflation moderating to 3.2%. The Materials sector also performed well, returning 5.0%, though the sector faced some volatility late in the month following Trump's announcement of global tariffs.

The domestic technology and utility sectors faced challenges. Macquarie Technology Group (-4.1%) declined amid broader tech sector uncertainty following China's DeepSeek AI announcement, while Origin Energy (-4.1%) struggled as utilities underperformed. The NAB business survey showed improving conditions but highlighted ongoing price pressures, particularly affecting consumer-facing sectors.

As we move forward, the portfolio maintains its focus on quality Australian companies with strong market positions. While global factors like U.S. trade policy and AI developments remain important, domestic considerations including the RBA's February meeting and the ongoing balance between inflation and mortgage stress will likely drive near-term market direction.

Defensive Income

2025 started with largely solid performance for global fixed income. US economic data showed a continued tempering of inflation, alongside a buoyant labour market and the Federal Reserve kept interest rates unchanged at 4.25 – 4.50%. The US 10y yield closed the month steady at 4.55%, although at one stage got as high as 4.8%. High yield spreads compressed, down 10bps to 300bps on the CDX HY 5y spread.

The Australian bond market saw a material steepening in the curve, particularly at the longer end. The domestic ACGB 10y yield increased 7bps to 4.43%, but our 2y yield fell 6bps to 3.80% (vs 4bps fall in the US). A better-than-expected decline in local inflation has the market primed for an 18-Feb rate cut. Year-on-year trimmed mean CPI is running at 3.2% vs survey of 3.3%. Domestic credit spreads were stable month-on-month, with the AusBond Credit FRN OAS 2bps wider at 65bps. The AusBond Credit BBB- to BBB+ OAS fell 2bps to 121bps. Our 5y constant tenor Big Four Tier 2 FRN spread widened 3bps to 148bps.

Prime’s Defensive Income Portfolio delivered a robust return of +0.58% in January, marking a strong start to 2025. This performance contributed to an impressive 1y and 2y return of +6.98% and +6.52% p.a., outperforming the Bank Bill Index by +2.51% and +2.29%, respectively. Positively, this has been achieved with no negative months recorded since May 2023 (which was a modest negative 3bps). This excellent performance has been achieved while maintaining consistently low exposure to interest risk (~1.5y duration) and high credit quality (A- portfolio average credit rating). All underlying holdings contributed a positive return in January. The top performers for the Portfolio were Metrics Direct Income Fund (+0.71%) and MA Priority Income Fund (+0.71%), both contributing weighted returns of +9bps. MQGPF was the lowest contributer (+1bps), at the time of writing, this position has now been sold out of the portfolio as we continue to decrease our exposure to AT1 hybrids which are trading at historically tight margins.

International Equities

The Prime International Growth Portfolio returned 3.6% in January. The month was characterised by significant market volatility driven by President Trump's implementation of new tariffs, developments in the AI sector, and varying regional performance.

The iShares Europe ETF was the standout performer, returning 6.5% despite broader market uncertainty. The Aoris International Fund (+5.9%) and Munro Concentrated Global Growth Fund (+5.0%) also delivered strong returns, benefiting from positive earnings results in the tech sector and a broadening market rally early in the month.

Value-oriented strategies showed resilience, with the Pzena Global Focused Value Fund returning 4.7% as investors sought companies with strong fundamentals amid the uncertain trade environment.

The portfolio's U.S. exposure through the iShares S&P 500 ETF (+2.9%) delivered modest returns, reflecting the mixed impact of strong corporate earnings offset by concerns over new tariffs targeting Canada, Mexico, and China. The Langdon Global Smaller Companies Fund (+2.4%) demonstrated relative stability despite typically higher sensitivity to trade policy changes.

As we move forward, investor attention remains divided between the potential economic impacts of the newly imposed tariffs and the rapidly evolving AI landscape, particularly following China's DeepSeek announcement. These developments, combined with ongoing corporate earnings releases, suggest markets may continue to experience heightened volatility in the near term.

Contact

Mark Johnson
T: (03) 8825 4738
Marcus Ainger
T: (02) 9134 6292
Dylan Cresswell 
T: (03) 8825 4707
Brent Quinn
T: (03) 8825 4705
Livio Caiolfa 
T: (03) 8825 4748
Gina McIntosh
T: (07) 3557 2557
Jarrod Rodda 
T: (03) 8825 4729
Dylan Mayes ‍
T: (03) 8825 4742
 

The information in this article contains general advice and is provided by Primestock Securities Ltd AFSL 239180. That advice has been prepared without taking your personal objectives, financial situation or needs into account. Before acting on this general advice, you should consider the appropriateness of it having regard to your personal objectives, financial situation and needs. You should obtain and read the Product Disclosure Statement (PDS) before making any decision to acquire any financial product referred to in this article. Please refer to the FSG (www.primefinancial.com.au/fsg) for contact information and information about remuneration and associations with product issuers. This information should not be relied upon as a substitute for professional advice, and we encourage you to seek specific advice from your professional adviser before making a decision on the matters discussed in this article. Information in this article is current at the date of this article, and we have no obligation to update or revise it as a result of any change in events, circumstances or conditions upon which it is based.

Thank you for submitting your details, now you can download here.
Download Now
Oops! Something went wrong while submitting the form.
Thank you for submitting your details.
Oops! Something went wrong while submitting the form.

Take up this one-time exclusive offer and choose the service and expertise you need to make your SMSF work for you, speak to a specialist today to get started.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Terms & Conditions:
The promotion is not valid for cash or cash equivalent and is non-transferable. Cannot be combined with other offers, discount promotions or promotions. Promotions may be subject to availability. All monetary amounts specified in these terms and conditions are in Australian dollars (AUD). All pricing excludes GST. To redeem this promotion during the promotional period, you must complete the form submission included in the communication or landing page. Stock Doctor, Bell Direct and Prime reserves the right to modify or amend this promotion and cancel or suspend the promotion without prior notice. By completing the form or attempting to participate in this promotion, you agree to accept and be bound by these terms and conditions from StockDoctor, BellDirect and PrimeFinancial. The promotion from Bell Direct starts on Friday 27th October 2023 at 9:00 am AEDT and ends on Thursday 7th December 2023 at 5:00 pm AEDT. The promotion from Prime starts on Friday 27th October 2023 at 9:00 am AEDT and ends on Thursday 7th December 2023 at 5:00 pm AEDT. The promotion includes from StockDoctor: a 30-day complimentary membership to Stock Doctor. The promotion starts on Friday 27th Oct 2023 at 9:00 am AEDT and ends on Sunday 24th December 2023 at 5:00 pm AEDT and $200.00 AUD discount on new members joining Stock Doctor. The promotion starts on Friday 27th Oct 2023 at 9:00 am AEDT and ends on Sunday24th March 2024 at 5:00 pm AEDT.

Disclaimer:
This information has been prepared by Primestock Securities Limited ABN 67 089 676 068, AFSL 239180 ('Prime'). Prime accepts no obligation to correct or update the information or opinions in it. This information does not take into account your objectives, financial situation or needs. Before acting on this information, you should consider whether it is appropriate to your situation. It is recommended that you obtain financial, legal and taxation advice before making any financial investment decision. Prime is bound by the Australian Privacy Principles for the handling of personal information. Privacy Policy | Financial Services Guide

Lincoln Indicators Pty Limited (Lincoln) ABN 23 006 715 573, as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751966, AFSL 483167. This communication may contain general financial product advice or forward-looking statements regarding our intent, belief or current expectations with respect to the market conditions. Caution is advised in placing undue reliance on these forward-looking statements, as our advice has been prepared without taking account of your personal circumstances. Therefore, you should consider its appropriateness, in light of your objectives, financial situation and needs, before acting on it. Before acting on any advice, you should consider the appropriateness of the advice, and we recommend you obtain financial, legal and taxation advice before making a decision. Please refer to our Financial Services Guide (FSG) for more information at Lincoln Indicators Pty Ltd. If our advice relates to the acquisition or possible acquisition of a particular financial product, you should obtain a copy of and consider the Product Disclosure Statement (PDS) at Lincoln Indicators Pty Ltd before making any decision. 

The Bell Direct service is provided by Third Party Platform Pty Limited trading as "Bell Direct" (ABN 74 121 227 905) an Australian financial services licensee (AFSL 314341) a Participant of the ASX Limited Group and a Trading Participant of Cboe Australia. Bell Direct does not provide investment advice. You should consider your own financial situation, particular needs and investment objectives before acting on any of the information available at https://www.belldirect.com.au/.

Testimonials are provided by third parties for information purposes only and are not intended, and should not be taken to be financial product advice. Please refer to “Terms of Use”, “Important Information”, Terms and Conditions and The Privacy Policy Guide for StockDoctor, BellDirect and Prime for more information.

Contact details:
Email:
katea@primefinancial.com.au
Phone: 03 8825 4745

A unique and personal service approach to support all your business advisory and personal wealth management needs.

wealth strategies